YANG GANG,HUANG LIANFENG,HUI HO-WAH,NARINGREKAR VIJAY
申请号:
NZ63031114
公开号:
NZ630311A
申请日:
2014.09.08
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
Disclosed are formulations comprising romidepsin (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone) in a concentration of 1 mg/mL to 10 mg/mL and a citrate or acetate buffer. The formulation is useful in the treatment of cancer.